Browse by UCL Departments and Centres
![]() | Up a level |
Group by: Author | Type
Number of items: 22.
B
| BOWLER, JV and WADE, JPH (1989) TC-99M-HMPAO UPTAKE AND WASHOUT IN STROKE. LANCET , 1 (8647) 1140 - 1141. |
| BREMNER, FD and FARMER, C and FARMER, SF and INGRAM, DA and STEPHENS, JA and SWASH, M (1989) CHANGES IN THE TIME COURSE OF MOTOR UNIT SYNCHRONIZATION FOLLOWING UPPER MOTONEURON LESIONS IN MAN SUGGEST AN INCREASE IN MOTONEURON EPSP AMPLITUDES. J PHYSIOL-LONDON , 417 P103 - P103. |
C
| Canavan, AG and Passingham, RE and Marsden, CD and Quinn, N and Wyke, M and Polkey, CE (1989) The performance on learning tasks of patients in the early stages of Parkinson's disease. Neuropsychologia , 27 (2) 141 - 156. |
| CANAVAN, AGM and PASSINGHAM, RE and MARSDEN, CD and QUINN, N and WYKE, M and POLKEY, CE (1989) SEQUENCING ABILITY IN PARKINSONIANS, PATIENTS WITH FRONTAL-LOBE LESIONS AND PATIENTS WHO HAVE UNDERGONE UNILATERAL TEMPORAL LOBECTOMIES. NEUROPSYCHOLOGIA , 27 (6) 787 - 798. |
| Coleman, RJ and Lange, KW and Quinn, NP and Loper, AE and Bondi, JV and Hichens, M and Stahl, SM and Marsden, CD (1989) The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results. Mov Disord , 4 (2) 129 - 138. 10.1002/mds.870040204. |
| COLEMAN, RJ and TEMLETT, JA and QUINN, NP and STAHL, SM and MARSDEN, CD (1989) A STRATEGY FOR MEASURING THE THERAPEUTIC PROPERTIES OF NEW ANTIPARKINSONIAN DRUGS, SUCH AS +PHNO, IN PATIENTS WITH ON-OFF FLUCTUATIONS. CLIN NEUROPHARMACOL , 12 (1) 37 - 45. |
E
| EARDLEY, I and QUINN, NP and FOWLER, CJ and KIRBY, RS and PARKHOUSE, HF and MARSDEN, CD and BANNISTER, R (1989) THE VALUE OF URETHRAL SPHINCTER ELECTROMYOGRAPHY IN THE DIFFERENTIAL-DIAGNOSIS OF PARKINSONISM. BRIT J UROL , 64 (4) 360 - 362. |
F
| FARMER, SF and INGRAM, DA and ROCHE, SW and STEPHENS, JA (1989) EVIDENCE THAT MIRROR MOVEMENTS IN THE KLIPPEL-FEIL SYNDROME IN MAN ARE PRODUCED BY ACTIVITY IN BRANCHED-STEM PRESYNAPTIC INPUTS FROM CORTICOSPINAL NEURONS. J PHYSIOL-LONDON , 418 P102 - P102. |
| FLETCHER, NA and QUINN, N (1989) DYSTONIC SYNDROMES. CURR OPIN NEUROL NEU , 2 (3) 330 - 333. |
H
| HUSAIN, M (1989) MODELING OF SACCADES. NEUROLOGY , 39 (12) 1646 - 1647. |
K
| Kapoor, R and Pirtosek, Z and Frankel, JP and Stern, GM and Lees, AJ and Bottomley, JM and Haran, NS (1989) Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468. Lancet , 1 (8652) 1445 - 1446. |
| Kapoor, R and Webb, C and Greenfield, SA (1989) Endogenous dopamine modifies electroresponsiveness of pars compacta cells in guinea-pig substantia nigra in vitro. Exp Brain Res , 74 653 - 657. |
| Kermode, AG and Rudge, P and Thompson, AJ and du Boulay, EPGH and McDonald, WI (1989) MRI of thoracic cord in tropical spastic paraparesis. In: Society of Magnetic Resonance in Medicine. 8th Annual scientific meeting and exhibition, Amsterdam. Book of Abstracts. (729 - ?). |
P
| PULLEN, A (1989) Immunochemical and quantitative ultrastructural analyses of experimental diphtheritic neuronopathy in cat. In: Neuroscience Letters. (pp. S95 - S95). Elsevier Science: London. |
| PULLEN, A (1989) Synaptic replacement in thoracic motor neurones following chronic partial central deafferentation. Neuropathology and Applied Neurobiology , 15 271 - 272. |
Q
| QUINN, N (1989) DISPROPORTIONATE ANTECOLLIS IN MULTIPLE SYSTEM ATROPHY. LANCET , 1 (8642) 844 - 844. |
| QUINN, N (1989) MULTIPLE SYSTEM ATROPHY - THE NATURE OF THE BEAST. J NEUROL NEUROSUR PS 78 - 89. |
| QUINN, N (1989) MYOCLONUS ASSOCIATED WITH HIGH-DOSES OF MORPHINE. BRIT MED J , 299 (6700) 683 - 684. |
| QUINN, N (1989) PREDICTIVE TESTING FOR HUNTINGTONS-DISEASE WITH LINKED DNA MARKERS. LANCET , 2 (8668) 921 - 921. |
| QUINN, N and HALLETT, M (1989) DOSE STANDARDIZATION OF BOTULINUM TOXIN. LANCET , 1 (8644) 964 - 964. |
| QUINN, NP and LUTHERT, P and HONAVAR, M and MARSDEN, CD (1989) PURE AKINESIA DUE TO LEWY BODY PARKINSONS-DISEASE - A CASE WITH PATHOLOGY. MOVEMENT DISORD , 4 (1) 85 - 89. |
T
| TEMLETT, JA and QUINN, NP and MARSDEN, CD and LATASTE, X and JATON, AL (1989) THE ANTIPARKINSONIAN ACTIVITY OF CQA 206-291, A NEW D2 DOPAMINE RECEPTOR AGONIST. CLIN NEUROPHARMACOL , 12 (1) 55 - 59. |


